SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : A US National Health Care System?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lane3 who wrote (4118)1/29/2008 3:24:43 PM
From: TimF  Read Replies (1) of 42652
 
What's wrong?

Well there is no consideration of the positive side of not getting treatment or tests if your exposed to at least some of its cost. Many tests don't tell a whole lot (the false positive rate may be fairly low, but if the incidence is also low you may have more chance to have a false positive than a real positive if the rest shows you have the condition). I'm not sure if this idea applies to breast cancer or not (after all breast cancer isn't a rare disease) but it does often apply. Also tests can themselves be harmful, as can treatments in response to false positives.

Another thing is it doesn't speculate about any differences in the plans or the people likely to pick each plan, other than the copayments that might be a factor in mammogram rates.

Moving away from just considering mammograms, letting people feel some of the cost and decide based on that whether they will have a procedure is generally a good thing. Containing costs is important, as resources are always and everywhere limited. The savings can even increase health care quality because they might be used to deal with other health care concerns.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext